UnknownPhase 3NCT01398644

Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients

Studying Hereditary Hemochromatosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sanquin Research & Blood Bank Divisions
Principal Investigator: Eva Rombout, MD, LCSW
Sanquin Blood Supply
Intervention: Phlebotomy and erythrocytapheresis(other)
Enrollment: 40 enrolled
Eligibility: 18-90 years · All sexes
Timeline: 2008 – 2013

Study locations (1)

University Hospital Maastricht, Maastricht, Netherlands

Collaborators

Maastricht University Medical Center · Atrium Medical Center · Radboud University Medical Center · Orbis Medical Centre

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01398644 on ClinicalTrials.gov

← Back to all trials